Skip to main content
. 2018 May 16;6:36. doi: 10.1186/s40425-018-0337-7

Fig. 6.

Fig. 6

Changes in circulating T cells. (a) Percentages of circulating CD4 and CD8 T cells in complete and partial responders responders before and after T-VEC plus pembrolizumab (b) CD4:CD8 ratios complete and partial responders responders before and after T-VEC plus pembrolizumab. (c) Percentages of PD1+ CD4 and CD8 T cells in complete and partial responders responders before and after T-VEC plus pembrolizumab